Home›Research›Compare›Cagrilintide vs Pramlintide
Peptide Comparison
Cagrilintide vs Pramlintide
Both are Fat Loss peptides.
Cagrilintide
AM833
Half-life: ~7 days
13 providers listed
Pramlintide
Symlin
Half-life: ~48 minutes
No providers listed yet
Quick Verdict
Cagrilintide
Risk
Half-life
~7 days
Pramlintide
Risk
Half-life
~48 minutes
Side-by-Side Comparison
About Cagrilintide
Long-acting amylin analogue; acts on amylin/calcitonin receptors to prolong satiety; synergistic with semaglutide in CagriSema combination
A once-weekly long-acting amylin analogue in late-stage development. Showing impressive weight loss (~15%) in trials, especially when combined with semaglutide (CagriSema).
Research Areas
About Pramlintide
Synthetic amylin analogue; activates amylin receptors in hypothalamus; slows gastric emptying, suppresses glucagon, enhances satiety
FDA-approved synthetic amylin analogue that complements insulin therapy. Reduces postprandial glucose spikes and suppresses appetite, aiding weight management in T1D and T2D.
Research Areas
Find Providers
Where to source these peptides
Providers offering
Cagrilintide
13 listed
Browse directory →
Providers offering
Pramlintide
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More fat loss Comparisons
Browse all peptides →Educational research tools — not medical advice.